CN110013536A - 一种含砭石中草药膏剂及其制备方法 - Google Patents
一种含砭石中草药膏剂及其制备方法 Download PDFInfo
- Publication number
- CN110013536A CN110013536A CN201810019197.1A CN201810019197A CN110013536A CN 110013536 A CN110013536 A CN 110013536A CN 201810019197 A CN201810019197 A CN 201810019197A CN 110013536 A CN110013536 A CN 110013536A
- Authority
- CN
- China
- Prior art keywords
- herbal medicine
- chinese herbal
- radix
- stone needle
- paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000411851 herbal medicine Species 0.000 title claims abstract description 41
- 239000004575 stone Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 22
- 235000008397 ginger Nutrition 0.000 claims abstract description 22
- 241000272534 Struthio camelus Species 0.000 claims abstract description 18
- 241000758794 Asarum Species 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 17
- 241000545744 Hirudinea Species 0.000 claims abstract description 17
- 241000282346 Meles meles Species 0.000 claims abstract description 17
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 17
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 17
- 241000132171 Phryma leptostachya Species 0.000 claims abstract description 17
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 16
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 16
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 16
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 16
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 16
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 16
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 16
- 241000779819 Syncarpia glomulifera Species 0.000 claims abstract description 16
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 16
- 239000001739 pinus spp. Substances 0.000 claims abstract description 16
- 229940036248 turpentine Drugs 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims description 22
- 239000003595 mist Substances 0.000 claims description 17
- 241000234314 Zingiber Species 0.000 claims description 13
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 238000004090 dissolution Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000002653 magnetic therapy Methods 0.000 claims description 5
- 238000001467 acupuncture Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 55
- 208000002193 Pain Diseases 0.000 description 17
- 239000003814 drug Substances 0.000 description 17
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 10
- 201000004624 Dermatitis Diseases 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 8
- 231100000869 headache Toxicity 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 description 6
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 208000036319 cervical spondylosis Diseases 0.000 description 6
- 208000005801 spondylosis Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 231100000241 scar Toxicity 0.000 description 5
- 206010001233 Adenoma benign Diseases 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 208000037093 Menstruation Disturbances Diseases 0.000 description 4
- 206010027339 Menstruation irregular Diseases 0.000 description 4
- 208000007101 Muscle Cramp Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 208000002938 adenomyoma Diseases 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 208000002352 blister Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000008338 local blood flow Effects 0.000 description 4
- 230000001926 lymphatic effect Effects 0.000 description 4
- 210000005075 mammary gland Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 210000002460 smooth muscle Anatomy 0.000 description 4
- 238000013268 sustained release Methods 0.000 description 4
- 239000012730 sustained-release form Substances 0.000 description 4
- 201000004647 tinea pedis Diseases 0.000 description 4
- 208000004371 toothache Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010034464 Periarthritis Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000229143 Hippophae Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 description 1
- 208000002740 Muscle Rigidity Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000002240 Tennis Elbow Diseases 0.000 description 1
- 208000004760 Tenosynovitis Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002239 ischium bone Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Radiology & Medical Imaging (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种含砭石中草药膏剂,原料组成包括:砭石20‑30g、沙棘20‑30g、红花10‑20g、三七10‑20g、川芎10‑15g、没药10‑15g、水蛭5‑10g、细辛5‑10g、松节5‑10g、透骨草20‑30g、生姜5‑10g、独活10‑15g、羌活10‑15g,防风5‑10g、陈皮5‑10g、薄荷3‑5g、獾油30‑40g、鸵鸟油20‑30g、活力霜20‑30g,再通过制备方法,把原料融合在一起,实现了将膏剂运用到临床,并且疗效又快又好、无副作用、方便快捷、体感舒适、成本低。
Description
技术领域
本发明涉及医药技术领域,更具体的说是涉及一种含砭石中草药膏剂及其制备方法。
背景技术
在《黄帝内经》中提出:病有内症、外症之分,治有内治、外治之义,同时提出了“外治法”可以“统治百病”,又因为内治法过程繁琐、疗效慢、有副作用、有创伤和成本高,远不如外治法受欢迎;在清代医家吴师机的《理瀹骈文》中又提到:病在外者,贴敷局部,病在内者,贴敷要穴,即将膏剂运用到临床。
但是,膏剂运用到临床也一直存在一些问题:一方面外用药除极少中药外很少吸收的成分与内服也有差异;另一方面,传统中医药理论的形成是在内服为主题的前提下形成的,内服的功效与外用功效有差异,但绝大多数中药并没有体现出来,以内服为基础形成的理论来外推外用情况,会导致较大变化。
因此,对中药外用功效进行研究,在中药外用功效的基础上,依据中医的经络传感,并结合现代透皮吸收、全息理论等进一步完善外治,将含砭石中草药膏剂运用到临床,并且疗效又快又好、无副作用、方便快捷、体感舒适、成本低是本领域技术人员亟需解决的问题。
发明内容
有鉴于此,本发明提供了一种含砭石中草药膏剂,疗效又快又好、无副作用、方便快捷、体感舒适、成本低,完善了外治法。
为了实现上述目的,本发明采用如下技术方案:
一种含砭石中草药膏剂,其中含砭石中草药膏剂的原料组成包括:砭石 20-30g、沙棘20-30g、红花10-20g、三七10-20g、川芎10-15g、没药10-15g、水蛭5-10g、细辛5-10g、松节5-10g、透骨草20-30g、生姜5-10g、独活10-15g、羌活10-15g,防风5-10g、陈皮5-10g、薄荷3-5g、獾油30-40g、鸵鸟油20-30g、活力霜20-30g。
通过采取以上方案,本发明的有益效果是:
(1)通过各个原料的相互融合和比例的配合,膏剂缓释通过经络到达人体病灶,从而达到治病、祛病、防病的作用;其作用不仅涉及浅层,还涉及深层,通过物质组成温热刺激,使局部皮肤充血,毛细血管扩张,增强局部的血液循环与淋巴循环,缓解和消除平滑肌痉挛,使局部的皮肤组织代谢能力加强,促进炎症、瘢痕、浮肿、粘连、渗出物、血肿等病理产物消散吸收,从而达到了疗效又快又好、无副作用、方便快捷、体感舒适、成本低的效果;
(2)主要用于治疗颈椎病、腰椎痛、风寒腿、头痛、牙痛;宫寒、月经不调、痛经、乳腺增生,腺肌瘤;湿疹、皮炎、脚气、疱疹、感冒、发烧;高血压、高血脂、高血糖;经络不通、气血不通、排泄不通。
进一步的,包括的原料组成为:砭石20g、沙棘25g、红花15g、三七10g、川芎10g、没药10g、水蛭5g、细辛5g、松节5g、透骨草20g、生姜10g、独活15g、羌活15g,防风5g、陈皮10g、薄荷5g、獾油30g、鸵鸟油25g、活力霜25g。
采用上述技术方案的有益技术效果在于:
(1)砭石功效:含有三十多种有益于人体的微量元素和矿物质,远红外射线、微晶结构、超声波脉冲。具有消除腰部赘肉、驱减脂肪、润白皮肤、健美修形的作用,对于减肥也有显著疗效。砭石,舒缓紧张情绪、减轻压力,有镇定、安神作用。加速体内血液循环、打开毛孔,打通身体内环境,彻底排出身体污物。激活身体休眠细胞,增强人体免疫力,促进伤口愈合。加强气管、支气管及肺部功能,对脱敏、排痰有良好的作用。排出汗水和积聚在体内的毒素,能够减轻关节炎、肠胃病、慢性支气管炎等症状。增加身体基础代谢,降低血糖、胆固醇、甘油三脂,增加运动耐力。抑菌、促进肌体修复与再生功能。美白肌肤,改变皮肤肤质,增强皮肤弹性,延缓衰老,改善酸性体质及治疗都市人群亚健康状态,对睡眠及神经衰弱有很好功效。
(2)沙棘功效:止咳祛痰,消食化滞,活血散瘀,用于咳嗽痰多、消化不良、食积腹痛、跌扑瘀肿、瘀血经闭。
(3)红花功效:活血通径、散瘀止痛,用于经闭、痛经、恶露不行、症瘕痞块、跌打损伤。
(4)三七功效:具有止血、活血化瘀、消肿定痛、滋补强壮、抗疲劳、耐缺氧、抗衰老、降血脂、降血压、提高机体免疫功能等作用。
(5)川芎功效:活血行气,祛风止痛,川芎辛温香燥,走而不守,既能行散,上行可达巅顶;又入血分,下行可达血海,川芎为血中之气药。
(6)没药功效:具有散瘀定痛,消肿生肌之功效;常用于胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,癥瘕腹痛,风湿痹痛,跌打损伤,痈肿疮疡等病症的治疗。
(7)水蛭功效:具有防治心脑血管疾病和抗癌方面具有特效;具有治疗中风、高血压、清瘀、闭经、跌打损伤等功效。
(8)细辛功效:祛风燥湿,活血止痛,通络开窍;治风冷头痛,鼻渊,齿痛,痰饮咳逆,风湿痹痛。
(9)松节功能:祛风除湿,该品辛温,辛能行散,温胜寒湿,舒筋活络。
(10)透骨草功效:祛风除湿、舒筋活络,活血止痛、解毒化疹。
(11)生姜功效:生姜具有发汗解表,温肺止咳,解毒的功效,可治外感风寒、胃寒呕吐、风寒咳嗽、腹痛腹泻、中鱼蟹毒等病症;具有解毒杀菌的作用,生姜中的姜辣素进入体内,能产生一种抗氧化本酶,它有很强的对付氧自由基的本领,比维生素E还要强得多;生姜能刺激胃粘膜,引起血管运动中枢及交感神经的反射性兴奋,促进血液循环,振奋胃功能,达到健胃、止痛、发汗、解热的作用;姜还能增强胃液的分泌和肠壁的蠕动,从而帮助消化;具有显著抑制皮肤真菌和杀死阴道滴虫的功效,可治疗各种痈肿疮毒。生姜有抑制癌细胞活性、降低癌的毒害作用,可以起到防癌的功效。
(12)独活功效:祛风除湿、痛痹止痛,主治风寒湿痹、要洗疼痛、少阴伏风头痛、风寒挟湿头痛。
(13)羌活功效:解表散寒,祛风胜湿,止痛。
(14)防风功效:具有祛风解表,除湿止痛,疏肝解痉,杀虫止痒的功效;
(15)陈皮功效:理气健脾,燥湿化痰。
(16)薄荷功效:辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症;外用可治神经痛、皮肤瘙痒、皮疹和湿疹等。
(17)獾油功效:清热解毒,消肿止痛,用于轻度水、火烫伤,皮肤肿痛。
(18)鸵鸟油功效:迅速修复损伤的组织细胞、舒通经络、消炎止痛。主要针对症状:颈椎病、肩周炎、网球肘、腰间盘突出、坐骨疼、关节炎、风湿、类风湿等;鸵鸟油能在极短时间内舒缓、消除因关节炎、肌肉僵硬、颈椎病、肩周炎、腱鞘炎、鼻炎、腰椎间盘突出的肩膀僵硬所引起的疼痛,具有滋润皮肤,消除皱纹和抑制疤痕形成等多种功能。
(19)活力霜功效:活力霜的主要成分有白藜芦醇、丝氨酸、秦皮甲素、益母草、胡椒籽、紫苏、虾青素、橙皮苷等,可以缓解疼痛,修复细胞,疏通经络,恢复体质。
进一步的,一种含砭石中草药膏剂的制备方法,包括以下步骤:
(1)选择优秀的中草药:沙棘、红花、三七、川芎、没药、水蛭、细辛、松节、透骨草、生姜、独活、羌活,防风、陈皮、薄荷;
(2)把优质的中草药按照比例配制,通过萃取技术加工成微粉;
(3)把上述中草药微粉经过发酵技术发酵;
(4)将发酵的中草药微粉与砭石、獾油、鸵鸟油、活力霜溶解为一体,得到成本;
(5)将成品罐装,再经过量子技术植入48个小时后,得到磁疗产品。
进一步的,步骤(2)的微粉不小于200目。
采用上述技术方案的有益技术效果在于,把中医配方、现代中医萃取破皮技术、发酵技术和量子植入高科技技术完美系统化结合,是全国最先进的一套外用透皮技术。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
本发明实施例公开了一种含砭石中草药膏剂,其中含砭石中草药膏剂的原料组成包括:砭石20-30g、沙棘20-30g、红花10-20g、三七10-20g、川芎10-15g、没药10-15g、水蛭5-10g、细辛5-10g、松节5-10g、透骨草20-30g、生姜5-10g、独活10-15g、羌活10-15g,防风5-10g、陈皮5-10g、薄荷3-5g、獾油30-40g、鸵鸟油20-30g、活力霜20-30g,其制备方法,包括以下步骤:
(1)选择优秀的中草药:沙棘、红花、三七、川芎、没药、水蛭、细辛、松节、透骨草、生姜、独活、羌活,防风、陈皮、薄荷;
(2)把优质的中草药按照比例配制,通过萃取技术加工成微粉;
(3)把上述中草药微粉经过发酵技术发酵;
(4)将发酵的中草药微粉与砭石、獾油、鸵鸟油、活力霜溶解为一体,得到成品;
(5)将成品罐装,再经过量子技术植入48个小时后,得到磁疗产品。
具体的,经皮肤的渗透,膏剂缓释通过经络到达人体病灶,从而达到治病、祛病、防病的作用;其作用不仅涉及浅层,还涉及深层,通过物质组成温热刺激,使局部皮肤充血,毛细血管扩张,增强局部的血液循环与淋巴循环,缓解和消除平滑肌痉挛,使局部的皮肤组织代谢能力加强,促进炎症、瘢痕、浮肿、粘连、渗出物、血肿等病理产物消散吸收。
通过上述技术方案,把中医配方、现代中医萃取破皮技术、发酵技术和量子植入高科技技术完美系统化结合,优化了外治法,可以治疗颈椎病、腰椎痛、风寒腿、头痛、牙痛;宫寒、月经不调、痛经、乳腺增生,腺肌瘤;湿疹、皮炎、脚气、疱疹、感冒、发烧;高血压、高血脂、高血糖;经络不通、气血不通、排泄不通,并且,疗效又快又好、无副作用、方便快捷、体感舒适、成本低。
具体的,本实施例中选择砭石25g、沙棘20g、红花10g、三七10g、川芎 10g、没药10g、水蛭5g、细辛5g、松节5g、透骨草20g、生姜5g、独活10g、羌活10g,防风5g、陈皮5g、薄荷3g、獾油30g、鸵鸟油20g、活力霜20g。
实施例2:
本发明实施例公开了一种含砭石中草药膏剂,其中含砭石中草药膏剂的原料组成包括:砭石20-30g、沙棘20-30g、红花10-20g、三七10-20g、川芎10-15g、没药10-15g、水蛭5-10g、细辛5-10g、松节5-10g、透骨草20-30g、生姜5-10g、独活10-15g、羌活10-15g,防风5-10g、陈皮5-10g、薄荷3-5g、獾油30-40g、鸵鸟油20-30g、活力霜20-30g,其制备方法,包括以下步骤:
(1)选择优秀的中草药:沙棘、红花、三七、川芎、没药、水蛭、细辛、松节、透骨草、生姜、独活、羌活,防风、陈皮、薄荷;
(2)把优质的中草药按照比例配制,通过萃取技术加工成微粉;
(3)把上述中草药微粉经过发酵技术发酵;
(4)将发酵的中草药微粉与砭石、獾油、鸵鸟油、活力霜溶解为一体,得到成品;
(5)将成品罐装,再经过量子技术植入48个小时后,得到磁疗产品。
具体的,经皮肤的渗透,膏剂缓释通过经络到达人体病灶,从而达到治病、祛病、防病的作用;其作用不仅涉及浅层,还涉及深层,通过物质组成温热刺激,使局部皮肤充血,毛细血管扩张,增强局部的血液循环与淋巴循环,缓解和消除平滑肌痉挛,使局部的皮肤组织代谢能力加强,促进炎症、瘢痕、浮肿、粘连、渗出物、血肿等病理产物消散吸收。
通过上述技术方案,把中医配方、现代中医萃取破皮技术、发酵技术和量子植入高科技技术完美系统化结合,优化了外治法,可以治疗颈椎病、腰椎痛、风寒腿、头痛、牙痛;宫寒、月经不调、痛经、乳腺增生,腺肌瘤;湿疹、皮炎、脚气、疱疹、感冒、发烧;高血压、高血脂、高血糖;经络不通、气血不通、排泄不通,并且,疗效又快又好、无副作用、方便快捷、体感舒适、成本低。
具体的,本实施例中选择砭石20g、沙棘25g、红花15g、三七10g、川芎 10g、没药10g、水蛭5g、细辛5g、松节5g、透骨草20g、生姜10g、独活15g、羌活15g,防风5g、陈皮10g、薄荷5g、獾油30g、鸵鸟油25g、活力霜25g,这样,含砭石中草药膏剂原料组成为最佳比例,可以发挥最好的治疗效果。
实施例3:
本发明实施例公开了一种含砭石中草药膏剂,其中含砭石中草药膏剂的原料组成包括:砭石20-30g、沙棘20-30g、红花10-20g、三七10-20g、川芎10-15g、没药10-15g、水蛭5-10g、细辛5-10g、松节5-10g、透骨草20-30g、生姜5-10g、独活10-15g、羌活10-15g,防风5-10g、陈皮5-10g、薄荷3-5g、獾油30-40g、鸵鸟油20-30g、活力霜20-30g,其制备方法,包括以下步骤:
(1)选择优秀的中草药:沙棘、红花、三七、川芎、没药、水蛭、细辛、松节、透骨草、生姜、独活、羌活,防风、陈皮、薄荷;
(2)把优质的中草药按照比例配制,通过萃取技术加工成微粉;
(3)把上述中草药微粉经过发酵技术发酵;
(4)将发酵的中草药微粉与砭石、獾油、鸵鸟油、活力霜溶解为一体,得到成品;
(5)将成品罐装,再经过量子技术植入48个小时后,得到磁疗产品。
具体的,经皮肤的渗透,膏剂缓释通过经络到达人体病灶,从而达到治病、祛病、防病的作用;其作用不仅涉及浅层,还涉及深层,通过物质组成温热刺激,使局部皮肤充血,毛细血管扩张,增强局部的血液循环与淋巴循环,缓解和消除平滑肌痉挛,使局部的皮肤组织代谢能力加强,促进炎症、瘢痕、浮肿、粘连、渗出物、血肿等病理产物消散吸收。
通过上述技术方案,把中医配方、现代中医萃取破皮技术、发酵技术和量子植入高科技技术完美系统化结合,优化了外治法,可以治疗颈椎病、腰椎痛、风寒腿、头痛、牙痛;宫寒、月经不调、痛经、乳腺增生,腺肌瘤;湿疹、皮炎、脚气、疱疹、感冒、发烧;高血压、高血脂、高血糖;经络不通、气血不通、排泄不通,并且,疗效又快又好、无副作用、方便快捷、体感舒适、成本低。
具体的,本实施例中选择砭石30g、沙棘30g、红花20g、三七20g、川芎 15g、没药15g、水蛭10g、细辛10g、松节10g、透骨草30g、生姜10g、独活 15g、羌活15g,防风10g、陈皮10g、薄荷5g、獾油40g、鸵鸟油30g、活力霜 30g。
本说明书中各个实施例采用递进的方式描述,每个实施例重点说明的都是与其他实施例的不同之处,各个实施例之间相同相似部分互相参见即可。对于实施例公开的装置而言,由于其与实施例公开的方法相对应,所以描述的比较简单,相关之处参见方法部分说明即可。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (4)
1.一种含砭石中草药膏剂,其特征在于,所述含砭石中草药膏剂的原料组成包括:砭石20-30g、沙棘20-30g、红花10-20g、三七10-20g、川芎10-15g、没药10-15g、水蛭5-10g、细辛5-10g、松节5-10g、透骨草20-30g、生姜5-10g、独活10-15g、羌活10-15g、防风5-10g、陈皮5-10g、薄荷3-5g、獾油30-40g、鸵鸟油20-30g、活力霜20-30g。
2.根据权利要求1所述的一种含砭石中草药膏剂,其特征在于,包括的原料组成为:砭石20g、沙棘25g、红花15g、三七10g、川芎10g、没药10g、水蛭5g、细辛5g、松节5g、透骨草20g、生姜10g、独活15g、羌活15g、防风5g、陈皮10g、薄荷5g、獾油30g、鸵鸟油25g、活力霜25g。
3.根据权利要求1所述的一种含砭石中草药膏剂的制备方法,其特征在于,包括以下步骤:
(1)选择优秀的中草药:沙棘、红花、三七、川芎、没药、水蛭、细辛、松节、透骨草、生姜、独活、羌活,防风、陈皮、薄荷;
(2)把优质的中草药按照比例配制,通过低温萃取技术加工成微粉;
(3)把上述中草药微粉经过发酵技术发酵;
(4)将发酵的中草药微粉与砭石、獾油、鸵鸟油、活力霜溶解为一体,得到成品;
(5)将成品罐装,再经过量子技术植入48个小时后,得到磁疗产品。
4.根据权利要求3所述的一种含砭石中草药膏剂的制备方法,其特征在于,所述步骤(2)的微粉不小于200目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810019197.1A CN110013536A (zh) | 2018-01-09 | 2018-01-09 | 一种含砭石中草药膏剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810019197.1A CN110013536A (zh) | 2018-01-09 | 2018-01-09 | 一种含砭石中草药膏剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110013536A true CN110013536A (zh) | 2019-07-16 |
Family
ID=67187780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810019197.1A Pending CN110013536A (zh) | 2018-01-09 | 2018-01-09 | 一种含砭石中草药膏剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110013536A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110169861A (zh) * | 2019-06-13 | 2019-08-27 | 陕西梦想医疗科技有限公司 | 一种多功能热敷仪 |
-
2018
- 2018-01-09 CN CN201810019197.1A patent/CN110013536A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110169861A (zh) * | 2019-06-13 | 2019-08-27 | 陕西梦想医疗科技有限公司 | 一种多功能热敷仪 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106798608B (zh) | 一种蜡疗用蜡泥及其制备方法 | |
CN102631413B (zh) | 一种治疗痤疮的中药组合物 | |
CN103272199A (zh) | 一种治疗冻伤的药物 | |
CN107998349A (zh) | 一种外敷泥灸及其制备方法 | |
CN105343645A (zh) | 一种治疗扁平疣的外用中药药膏 | |
CN103385941B (zh) | 中草药止痛药灸 | |
CN105194159A (zh) | 一种舒筋活血外用药酒 | |
CN104383445A (zh) | 一种跌打损伤止痛剂 | |
CN110013536A (zh) | 一种含砭石中草药膏剂及其制备方法 | |
CN1290571C (zh) | 外用刮痧拔罐保健治病药酒 | |
CN108721592A (zh) | 一种用于治疗肩颈痛的精油及其制备方法 | |
CN104324097B (zh) | 治疗痛痹型膝关节骨性关节炎的外用中药组合物 | |
CN107137529A (zh) | 一种治疗腕关节扭挫伤的中药膏剂及其制备方法 | |
CN106177047A (zh) | 膝关节消痹膏 | |
CN106177639A (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN103110739B (zh) | 治疗骨内伤的外用药酒和口服中药 | |
CN105663851A (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN101856440B (zh) | 一种治疗膝部肿痛的中药组合物 | |
CN104547032A (zh) | 用于瘀血痹阻证的中成药 | |
CN102380070B (zh) | 一种治疗足癣的外用中药 | |
CN104324108B (zh) | 治疗膝关节骨性关节炎(着痹)的外用中药组合物 | |
CN103656100B (zh) | 一种治疗心肌缺血的中草药 | |
CN107456551A (zh) | 一种治疗胃炎的中药 | |
CN101199650B (zh) | 一种治疗肩周炎的酊剂药物 | |
CN106420975A (zh) | 一种祛除寒痛瘀证的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190716 |
|
RJ01 | Rejection of invention patent application after publication |